F18 RADIOPHARMACEUTICALS

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

247-NETWORK CONTRACT OFFICE 7 (36C247)

Contract Value

Not provided

Codes & Classification
Solicitation Number

36C24726R0060

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

Q527

Additional Details
Set Aside

SDVOSBC

Place of Performance

Decatur, Georgia, UNITED STATES

SourceSAM
Documents2
The Department of Veterans Affairs, through its Network Contract Office 7 (36C247), has issued an amended solicitation (36C24726R0060) seeking qualified vendors to supply a range of radiopharmaceuticals to the Nuclear Medicine Service at the Atlanta Veterans Affairs Medical Center (ATL VAMC), located at 1670 Clairmont Road, Decatur, Georgia. This procurement is specifically set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSBC), in alignment with the VA’s commitment to supporting veteran entrepreneurs. The scope of this contract encompasses the provision of several specialized PET radiopharmaceuticals, including F18-FDG (fluorodeoxyglucose), F18-NaF (sodium fluoride), F18-Pylarify (Piflufolastat), CAIX targeted PET radiopharmaceuticals, choline PET radiopharmaceuticals, and F18-FET (Fluoro-Ethyl-Tyrosine). The selected contractor will be responsible for supplying these products on a daily basis, ensuring timely and reliable delivery to support the diagnostic and treatment needs of the Nuclear Medicine Service at the ATL VA Healthcare System. The contract is structured as a base period of one year, with the possibility of four additional one-year option periods, offering a potential five-year engagement. The contractor will be required to furnish all necessary labor, supervision, and transportation to fulfill the daily delivery requirements. This ensures continuity of care and uninterrupted access to critical radiopharmaceuticals for veteran patients. This opportunity falls under NAICS code 325412 (Pharmaceutical Preparation Manufacturing), with a Product Service Code of Q527, indicating a focus on medical and pharmaceutical products. The place of performance is exclusively at the ATL VAMC in Decatur, Georgia. Interested vendors should note that this is an active solicitation, with the most recent amendment revising certain line items—details of which are available in the updated attachment provided via the solicitation link. All inquiries and responses should be directed to the primary contracting contact, Natasha Mixon, at [email protected]. The response deadline for this opportunity is April 30, 2026, at 14:04. This procurement represents a significant opportunity for SDVOSBs with capabilities in the manufacturing and distribution of radiopharmaceuticals, particularly those with experience in serving healthcare institutions and meeting stringent delivery and quality requirements. Contractors should ensure they can meet the daily delivery schedule, maintain compliance with all applicable regulations, and provide the full range of specified radiopharmaceuticals throughout the contract term. For further details, including the amended line items and solicitation attachments, interested parties are encouraged to review the full notice and associated documents available at: https://sam.gov/opp/85b61aa9f4094a63a3fd36ad93ce01d9/view.